Dynavax Technolo (NASDAQ:DVAX) traded in a range yesterday that spanned from a low of $15.80 to a high of $18.25. Yesterday, the shares fell 13.2%, which took the trading range below the 3-day low of $18.60 on volume of 4.0 million shares. Often times ...
SmarTrend · 5d
Alliancebernstein Lp sold 56,370 shares as Dynavax Technologies Corp (DVAX)’s stock rose 5.85%. The Alliancebernstein Lp holds 74,920 shares with $1.40M value, down from 131,290 last quarter. Dynavax Technologies Corp now has $1.07 billion …
Bibey Post · 2d
Among 6 analysts covering Dynavax Technologies (NASDAQ:DVAX), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Dynavax Technologies had 27 analyst reports since August 12, 2015 according to SRatingsIntel. On Monday, January 22 the stock ...
Thorold News · 13d
A covered call identified by MarketIntelligececenter.com's patented algorithm on Dynavax Technologies (DVAX) could yield about 14.10% (20.69% annualized, for comparison purposes only) in 249 days. Pair a long position in the stock with the Jan 18 ...
Dr. Robert Janssen, M.D., serves as Chief Medical Officer, Vice President - Clinical Development and Regulatory Affairs of Dynavax Technologies Corporation effective July 9, 2013. He most recently served as Dynavax’s Vice President, Medical Affairs since ...
Reuters · 12d
The stock has more than tripled in the last 12 months. This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DVAX at https://www.zacks.com/ap/DVAX